/ Not yet recruitingPhase 1 评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群使用的安全性和免疫原性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
评价重组带状疱疹疫苗在40周岁及以上人群中使用的安全性和免疫原性。
[Translation] To evaluate the safety and immunogenicity of recombinant herpes zoster vaccine in people aged 40 years and above.
100 Clinical Results associated with Beijing Jinuo Sanitary Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Jinuo Sanitary Technology Co., Ltd.
100 Deals associated with Beijing Jinuo Sanitary Technology Co., Ltd.
100 Translational Medicine associated with Beijing Jinuo Sanitary Technology Co., Ltd.